Skip to main content
Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
10.95
-0.53 (-4.62%)
May 21, 2025, 4:00 PM - Market closed

Zenas BioPharma Revenue

Zenas BioPharma had revenue of $10.00M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $15.00M, down -70.00% year-over-year. In the year 2024, Zenas BioPharma had annual revenue of $5.00M, down -90.00%.

Revenue (ttm)
$15.00M
Revenue Growth
-70.00%
P/S Ratio
17.80
Revenue / Employee
$115,385
Employees
130
Market Cap
458.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.00M-45.00M-90.00%
Dec 31, 202350.00M--
Dec 31, 2022---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ZBIO News

More News